Breathe Well Live Well
|
UPDATE 1-AstraZeneca builds pipeline with $232 mln Synairgen asthma deal
Reuters LONDON, June 12 (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest … |
View full post on asthma – Google News
Reuters UK |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Fox Business AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest drugmaker – subject of a … AstraZeneca extends global shopping spree with $232M asthma drug deal Synairgen breathes easier with $225M from Astrazeneca for its asthma drug |
View full post on asthma – Google News
Reuters |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Reuters AstraZeneca plans to start a mid-stage Phase IIa study with the drug in early 2015 in patients with severe asthma, building on results from an initial Phase lla trial in a broad asthma population. Severe asthma is a growing focus for major drugmakers … Synairgen shares soar on AstraZeneca asthma deal AstraZeneca licenses rights to Synairgen asthma drug |
View full post on asthma – Google News
|
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Yahoo News LONDON (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest … AstraZeneca Licences Asthma Exacerbation Treatment From Synairgen AstraZeneca licenses rights to Synairgen asthma drug Synairgen shares soar on AstraZeneca asthma deal |
View full post on asthma – Google News